跳至主要内容
临床试验/JPRN-UMIN000010343
JPRN-UMIN000010343已完成未知

Evaluation of pharmacodynamics and safety of teneligliptin in type 2 diabetic patients with chronic renal dysfunction - Evaluation of pharmacodynamics and safety of teneligliptin in type 2 diabetic patients with chronic renal dysfunction

Kitano Hospital, The Tazuke Kofukai Medical Research Institute0 个研究点目标入组 12 人开始时间: 2013年3月28日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Type 1 diabetes,diabetes arising from the failure of pancreas,or secondary diabetes (eg. Cushing's syndrome and acromegaly) 2) Patient correspond to contraindications of teneligliptin 3) Excessive alcohol addicts: patient who take average net more than 60 g alcohol every single day (more than following: 3 bottles of sake, 1 with shochu, 3 bottles of beer, 3 glasses of whiskey or brandy(double),and 5 glasses of wine) 4) Pregnant, lactating, possible pregnant patient 5) Patient judged as ineligible for this study by the researcher

研究者

发起方
Kitano Hospital, The Tazuke Kofukai Medical Research Institute

相似试验